And Now, a Word from the FDA


Felix Frueh was hired by the FDA going on three years ago to serve as the associate director of genomics for the Office of Clinical Pharmacology, which itself is housed within the Office of Translational Sciences.

Frueh sat down with GT's Meredith Salisbury to talk about the growing relevance of genomics, proteomics, and more in the clinical realm. What follows is an excerpted transcript of the discussion.

Genome Technology: Why did FDA find it important to bring in someone to oversee genomics?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.